Aortic dissection et al Flashcards

1
Q

Aortic dissection: what it is and isnt

A

NOT an aneurysm

IS a result of a false lumen between intima and media of arterial wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of aortic dissection

A

Type A: affects ascending aorta and arch –> requires emergency surgery

Type B: begins in the descending aorta –> might be treatable with conservative management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aortic dissection: acute to chronic

A

symptom onset:
acute = first 14 days
subacute = 14-90 days
chronic = more than 90 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Etiology/pathophysiology of aortic dissection

A

Nontraumatic aortic dissection
-due to weakened elastic fibers in arterial wall
-chronic htn hastens the process
-tear in inner layer allows blood to surge between inner and middle layer
-rupture through outside wall can cause death

As heart contracts, each systolic pulsation increases the pressure on the damaged area, making it worse
-may occlude major branches of aorta –> cut off blood supply to brain, abdominal organs, kidneys, spinal cord, and extremeties

False lumen may remain patent, become thrombosed, or rejoin true lumen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aortic dissection: who does it affect?

A

men more than women
-if women have it, they’re usually old, with HF, coma, or altered mental status

HTN = biggest risk factor
-others: afe, aortic disease, atherosclerosis, blunt trauma, tobacco, cocaine/meth, congenital heart disease, CT disease, fam history, previous heart surgery, and pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical manifestation of aortic dissection Type A and B

A

Acute type A
-abrupt onset of severe anterior chest pain or back pain

Acute type B
-back, abdomen, or leg pain

*A and B can overlap
*pain described as “sharp”, “ripping”, “tearing”, “stabbing”, “worst ever”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dissection pain vs MI pain

A

-MI pain is more gradual w/ increased intensity
-dissection pain follows the path of the rip
-old ppl might not experience the intense pain –> vague symptoms and hypotension
-sometimes painless

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aortic dissection manifestations specific to aortic arch involvement

A

-Neurologic deficits
-disruption of blood flow in coronary arteries and aortic valve insufficiency
-if subclavian artery is involved, BP and arterial pulses are dif in arms
-can advance to descending aorta, decreasing tissue perfusion to abdominal organs and lower extremeties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aortic dissection complications

A

Cardiac tamponade
-severe, life-threatening complication of acute ascending aorta dissection
-happens when blood escapes from dissection into pericardial sac

Aorta may rupture, resulting in hemorrhage in mediastinal, pleural, or abdominal cavities –> exsanguination and death

Occlusion of arterial supply to vital organs: spinal cord, kidneys, abdominal organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

manifestations of cardiac tamponade

A

hypotension
narrowed pulse pressure
distended neck veins
muffled heart souds
pulsus paradoxus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aortic dissection diagnostic studies

A

H&P
ECG
Chest xray
CT
MRI
TEE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Immediate goals for aortic dissection in ICU

A

HR and BP control
-decrease BP and myocardial contractility to diminish pulsatile forces w/in aorta
-IV B-blocker to get HR below 60 or SBP100-110 –> can also try CCBs

Morphine for pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Conservative therapy for acute or chronic Type B w/o complications

A

pain relief
HR and BP control
CVD risk factor modification
close surveilance with CT or MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Endovascular dissection repair

A

Thoracic endovascular aortic repair TEVAR
-standart to treat acute and chronic type B aortic dissections with complications
-similar to EVAR, but fewer post-op complications
-may have lumbar drain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

surgical therapy for acute Type A aortic dissection

A

-emergency surgery (50% mortality)
-considered when drug therapy is ineffective or when complications of aortic dissection are present
-surgery is delayed to allow edema to decrease and permit clotting of blood

Involves resection of aortic segment and replacement with synthetic graft

Causes of death during surgery: aortic rupture, mesenteric ischemia, MI, sepsis, stroke, or multi-organ failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Preop aortic dissection

A

Semi Fowlers position and quiet enviro to decrease HR and BP
Anxiety and pain –> opioids and sedatives
Titrate IV antihypertensive agents
Continuous BP and ECG monitoring
VS every 2-3 mins (note changes in peripheral pulses)
Monitor for increaseing pain/restlessness/anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Postop aortic dissection

A

*same as for aneurysm

Discharge teaching
-long-term HR and BP control
-Antihypertensive drug and side effects as well as BBs and ACE-is
-regular follow up with CT or MRI

if pain returns or symptoms progress, seek immediate help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Phlebitis

A

acute inflammation of the walls of small cannulated veins of hand or arm (related to IV catheter) –> rarely infectious

Manifests: pain, tenderness, warmth, erythema, swelling, and palpable cord

Risks: irritation from catheter, infusion of irritating drugs, and catheter location at area of flexion

Treatment:
-elevate extremety for edema
-NSAIDs and warm, moist heat for pain/inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Venous thrombosis

A

-most common venous disorder
-formation of a thrombus with vein inflammation
-can be superficial (saphenous) or deep veins (iliac or femoral)
-VTE = DVT to pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Venous thrombosis Etiology

A

Virchow’s triad
-venous stasis
-damage to endothelium
-hypercoagulability of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Venous stases: VTE

A

-dysfunctional valves
-inactive extremety muscles

At risk if:
-obese
-pregnant
-chronic HF or afib
-traveling on long trips w/o exercise
prolonged surgery
-prolonged immobility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

endothelial damage: VTE

A

stimulates platelet activation and starts coagulation cascade which predisposes patient to thrombus development

Direct damage
-surgery, burns, IV catheter, trauma, prior VTE

Indirect damage
-chemotherapy, diabetes, sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hypercoagulability of blood: VTE

A

Occurs with many disorders:
-anemia and polycythemia
-cancr
-nephrotic syndrome
-high homocysteine levels
-coagulation disorders
-sepsis
-drugs: corticosteroids or estrogens
-smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Who has high risk of hypercoagulability

A

Women who:
-use tobacco (smoking increases plasma fibrinogen, homocysteine levels, and activates intrinsic coagulation pathway)
-are childbearing age and take E contraceptives
-are postmenopausal and take oral hormone therapy
-are over 35
-have fam history of VTE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pathophysiology of VTE

A

clot formation occurs when localized platelet aggregation and fibrin entrap RBCs, WBCs, and more platelets

Clot gets larer and has a “tail” that blocks the lumen of the vein

partial blockage = endothelial cells cover thrombus and stop growth; lysis or adherence w/in 5-7 days

detached thrombus results in embolus
-travels thru venous system to R side of heart and lodges in pulmonary circulation –> becomes PE
-turbulet bloodflow = major factor in embolization

26
Q

Superficial vein thrombosis

A

more common in legs

Manifestations
-palpable, firm, cordlike vein
-itchy, painful, red, warm
-mild fever, leukocytosis

Diagnosis: ultrasound

Treatment if under 5 cm and not near junction
-oral NSAIDs
-graduated compression stockings
-warm compresses
-elevate limb above heart
-mild exercise

27
Q

Manifestation of DVT

A

-in arms or legs, pelvis, vena cava, and pulmonary system

Lower extremety
-unilateral edema
-pain, tenderness with palpatation
-dialted superficial veins
-full sensation in thigh or calf
-paresthesias
-red and warm
-fever over 100.4

28
Q

manifestations of VTE in IVC and SVC

A

IVC
-legs edematous and cyanotic

SVC
-similar symptoms of arms, neck, back, and face

29
Q

VTE diagnosis

A

assessment, D-dimer, and/or ultrasound

30
Q

VTE complications

A

Serious:
-PE
-chronic thromboembolic pulmonary htn
-postthrombotic syndrome
-phlegmasia cerula dolens

31
Q

PTS
what is it?
symptoms?

A

-8-70% of VTE patients
-chronic inflammation and venous htn –> damage to vein walls and valves, venous valve reflux, and persistent venous obstruction

Symptoms
-pain, aching, fatigue, heaviness, swollen sensation, cramps, pruritus, tingling, paresthesia, pain with exercise, venous claudication

32
Q

PTS manifestations

A

edema, spider veins, venous dilation, redness, cyanosis, increased pigmentation, eczema, pain during compression, white scar tissue, lipodermatosclerosis

venous ulceration with severe PTS

signs may occur in a few months or years

33
Q

PTS risk factors

A

-persistant leg symptoms for more than 1 month after VTE
-VTE: proximal location, extensive or recurrent
-residual thrombus
-other: obesity, old age, poor INR control, tobacco use, increased D-dimer, increased inflammatory markers, varicose veins, and asymptomatic VTE

34
Q

VTE diagnostic studies

A

Blood: ACT, aPTT, INR, bleeding time, Hgb, Hct, platelet count, D-dimer, fibrin monomer complex

Noninvasive venous: venous compression ultrasound, duplex ultrasound

Invasive venous: CT venography, MR venography, contrast venography

35
Q

Prevention and prophylaxis for VTE

A

VTE prophylaxis is a core measure of high-quality health care in high-risk hospitalized patients

Early, aggressive mobilization
-walk 4-6x a day; flex joints every 2-4 hrs; oob

Graduated compression stockings
-use with anticoagulants
-don’t use if VTE already exists

Intermittent compression devices
-use with compression stockings (again, not if VTE exists)

Anticoagulants
-vit K antagonists, thrombin inhibitors, Factor Xa inhibitors

36
Q

Vit K antagonists

A

Warfarin
-inhibits vit K-dependent coagulation factors II, VII, IX, and X and anticoagulant prots C and S
-for long term or extended anticoagulation
-takes 48-72 hrs to be effective –> overlap with parenteral anticoagulant for 5 days
-monitor INR
-Antidote = vit K

Don’t give with antiplatelets or NSAIDs
AVOID VIT K
Genetics may alter response

37
Q

Thrombin INDIRECT inhibitors

A

UH (heparin) and LMWH
-affects intrinsic plasma antithrombin coagulation pathway; inhibits thrombin mediated conversion of fibrinogen to fibrin

Prophylaxis = subcutaneous

Existing VTE = continuous IV –> monitor aPTT

Heparin
-side effect = osteoporosis and heparin induced thrombocytopenia

LMWH (enoxaparin)
-more predictable with longer half life and fewer bleeding complications
-antidote = protamine

38
Q

DIRECT thrombin inhibitors

A

Hirudin derivative - bivalirudin (angiomax)
-binds with thrombin and inhibits function
-continuous IV

Synthetic (argatroban)
-hinders thrombin

Both
-indications: patient with or at risk for HIT having percutaneous coronary intervention
-monitor aPTT or ACT
-no antidote

Dabigatran (pradaxa) = oral
-indications: VTE prevention after elective joint replacement, for stroke prevention in nonvalvular atrial fibrillation, and as a treatment for VTE
-antidote: idarucizumab
-advantages over warfarin = rapid onset, no monitoring, few drug-food interactions, decreased risk of bleeding, predictable response

39
Q

Factor Xa inhibitors

A

Rapid anticoagulation
-VTE prophylaxis and treatment
-Fondaparinux (subq) is contraindicated for renal disease
-Rivaroxaba, apixaban, edoxaban = oral
-monitoring ot required but can use anti-Xa assays
-Andexant Alfa reverses rivaroxaban and apixaban

40
Q

Anticoagulant therapy for VTE prophylaxis

A

Hospitalized, non bleeding patiet
-UH, LMWH, or fondaparinux

Low risk VTE = none

Moderate risk = UH or LMWH
-general, GYN, or urologic surgery

High risk = UH or LMWH
-trauma, abdominal or pelvic surgery for cancer, or orthopedic surgery

41
Q

anticoagulant therapy for VTE treatment

A

Initial: LMWH, UH, or oral Factor Xa or VKA

INR - maintain 2-3 (VKA therapy)

Continue 3 or more months

Co morbidities, complex issues, or very large VTE requires hospitalization
-IV UH initially

42
Q

Thrombolytic therapy for VTE treatemet

A

Thrombolytic drug (tPA or urokinase) administered via catheter to dissolve clots, reduce acute symptoms, improve deep venous flow, reduce valvular reflux, and decrease PTS

Indication: patient with low risk of bleeding and has acute, extensive, symptomatic, proximal VTE

Must have systemic anticoagulation before, during, and after thrombolysis

43
Q

Surgical and interventional radiology therapies

A

Surgeries
1. Open venous thrombectomy
-incision into vein to remove clot

  1. Inferior Vena Cava interruption devices
    -filters placed via right femoral or jugular veins to trap clots without impeding blood flow
44
Q

Inferior vena cava interruption device

A

recommended for acute PE or proximal VTE of leg with active bleeding or if anticoagulation contraindicated or ineffective

Complications: air embolism, improper placement, filter migration, perforation of vena cava with retroperitoneal bleeding, clogged filter

45
Q

Percutaneous endovascular interventional radiology procedures for VTE

A

Mechanical thrombectomy
Pharmacomechanical devices
Post-thrombus extraction
angioplasty
stenting
***can be used with catheter-directed thrombolytic therapy

46
Q

Nursing care for VTE

A

maintain catheter systems
monitor for bleeding, embolization, and impaired perfusion
teach VTE prevention

47
Q

Acute care for VTE

A

Focus on prevention of thrombi and reduction of inflammation

Titrate drug doses and administer reversal agents a needed

monitor and reduce risk of bleeding

bed rest at first; then early ambulation and physical activity

48
Q

Ambulatory care for VTE

A

Avoid risk factors
-smoking, hormone therapy, travel, prolonged sitting

Drug side effects and routine blood tests and medic alert ID
-avoid falls
-apply pressure to bleeding sites for 10-15 mins
-no ASA or NSAIDs
-limit alcohol

If taking warfarin, eat vit K

Call EMS if
-bleeding
-headache, chest pain, stomach pain, palpitations, dyspnea, mental status changes
-inform HCP and dentist of anticoagulation

49
Q

Varicose veins

A

Dilated greater than 3 mm, tortuous superficial veins
-Primary = weakness of vein walls
-Secondary = direct injury, previous VTE, or excessive dilation
-Congenital = chromosomal defects
-Reticular = flat, less tortuous, blue-green
-Telangiectasias = spider veins less than 1 mm

50
Q

Varicose veins etiology and pathophysiology

A

Superficial veins in legs become dilated and tortuous from retrograde blood flow and increased venous pressure

Risk factors
-fam history of venous problems, female, tobacco use, aging, obesity, multiparity, history of VTE, venous obstruction, phlebitis, leg injury, prolonged sitting or standing

51
Q

manifestations of varicoe veins

A

heavy, achy feeling or pain after prolonged standing or sitting –> relieved by walking or limb elevation
-also: pressure, itchy, burning, tingling, throbbing, or cramp-like sensation

Complications
-Superficial venous thrombosis
-Also: rupture of varicosities results in bleeding and skin ulcerations

52
Q

varicose veins diagnosis and conservative treatment

A

Diagnosis
-examination
-duplex ultrasound

Conservative treatment
-ret with limb elevation
-graduated compression stockings
-leg strengthening exercises
-weight loss

53
Q

Drug therapy for varicose veins

A

Venoactive drugs
-antioxidants from plant extracts stimulate release of chems to strengthen the circulation and reduce inflammation and edema

Not FDA approved; available OTC and as herbal or dietary supplements
-micronized purified flavonoid fraction
-rutosides
-proanthocyanidins (apples and grapes)
-ruscus

54
Q

Varicose vein surgeries

A

Sclerotherapy - ablates vein by direct injection of sclerosis agent
-complications: residual pigmentation, matting, thrombophlebitis, and ulcers
-wear compression stocking and limit travel

Transcutaneous laser therapy or high-intensity pulsed light therapy
-complications: pain, blistering, hyperpigmentation and superficial erosions

Endovenous ablation = radiofrequency or laser therapy
-complications: bruising, burns, hyperpigmentation, infection, paresthesia, superficial or deep vein thrombosis, PE
-graduated compression stockings

55
Q

Interventional and surgical therapies

A

Traditional: ligation of vein and branches
Ambulatory phlebectomy
Transilluminated powered phlebectomy
-complications: bleeding, bruising, and infection

56
Q

postop varicose veins

A

deep breathing
neuro assessment
-evaluate legs
graduated compression stockings –> remove every 8 hrs for a while

57
Q

Chronic venous insufficiency

A

abnormalities of venous system including edema, skin changesm and venous leg ulcers

58
Q

CVI etiology and pathophysiology

A

-orimary varicose veins and PTS

Ambulatory venous htn
-serous fluid and RBC leak results in edema and chronic inflamatory changes
-hemosiderin = brown skin discoloration
-skin is hard, thick, and contracted

59
Q

manifestations of CVI

A

lower leg is brown, leathery, and edematous
eczema with itching and scratching

Venous ulcers

60
Q

Caring for venous ulcers

A

moist environment for wound
adequate protein, vit A/C, and zinc
keep diabetes in check
monitor for infection

61
Q

drugs for ulcers

A

pentoxifylline or micronized flavonoid fraction